상세 보기
Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.
- Ahn, Myung-Ju;
- Han, Ji-Youn;
- Kim, Sang-We;
- Lee, Ki Hyeong;
- Kim, Dong-Wan;
- ... Lee, Gyeong-won;
- 외 14명
Citations
WEB OF SCIENCE
3키워드
Lazertinib; T790M; 3rd generation EGFR TKI
- 제목
- Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.
- 저자
- Ahn, Myung-Ju; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Lee, Gyeong-won; Lee, Jong-Seok; Kim, Joo-Hang; Kim, Jin-Soo; Min, Young Joo; Lee, Sung Sook; Shin, Sang Won; Kim, HyeRyun; Hong, Min Hee; Ahn, Jin Seok; Lee, Seoung Oh; Kim, Sohee; Cho, Byoung Chul
- 발행일
- 2019-05-20
- 유형
- Meeting Abstract
- 권
- 37
- 호
- 15
- 언어
- ENG
- 출판사
- American Society of Clinical Oncology
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X